Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 7, 2025

November 7, 2025

Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025

GlobeNewswire

November 7, 2025

Draganfly to Host Shareholder Update Call on November 12, 2025

GlobeNewswire

November 7, 2025

Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea

GlobeNewswire

November 7, 2025

Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa

GlobeNewswire

November 7, 2025

Aduro Clean Technologies signe une lettre d’intention pour l’installation d’une usine de démonstration en Europe

GlobeNewswire

November 7, 2025

Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide

GlobeNewswire

November 7, 2025

Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue

GlobeNewswire

November 7, 2025

Ipsen présentera, lors de deux sessions « late-breaking » au congrès de l’AASLD, de nouvelles données sur la CBP confirmant l’efficacité et la tolérance à long terme d’IQIRVO® ainsi que de nouvelles analyses sur les mécanismes sous-jacents…

GlobeNewswire

November 7, 2025

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Lianhe Sowell International Group Ltd Announces Approval of Dual-Class Share Structure by Shareholders

GlobeNewswire

November 7, 2025

Champion Safe Celebrates Hyatt Coin Shop for 30% Year-Over-Year Growth in the Southeast

GlobeNewswire

November 7, 2025

ODYSIGHT.AI ANNOUNCES COMMERCIAL PURCHASE ORDER FOR 200 INDUSTRIAL PREDICTIVE MONITORING SYSTEMS FOR ELEVATORS

GlobeNewswire

November 7, 2025

New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism

GlobeNewswire

November 7, 2025

ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 7, 2025

IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment

GlobeNewswire

November 7, 2025

Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025

GlobeNewswire

November 7, 2025

Celldex to Present at Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting

GlobeNewswire

November 7, 2025

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

GlobeNewswire

November 7, 2025

Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique...

GlobeNewswire